Outside the Lab

Does point-of-care testing have a true positive effect on patient outcomes, or is it simply a perceived benefit?

New regulations in the US set to change the way LDTs are developed – and could stifle innovation

As more and more emerging study data fails to definitively support cancer screening, is it time for a study design overhaul?

A new screening method for clinically significant prostate cancer may provide more precision and reduce the risk of overtreatment

The demand for simple, point-of-care fingerprick testing is growing, but could a study highlighting drop-to-drop sample variation throw a spanner in the works?

Is almost complete reliance on technology a good thing?

Screening for pancreatic cysts can help with early detection and treatment – but how can we tell which lesions are benign and which may progress to cancer?

UK lab medicine experts team up with their counterparts in Africa to improve testing outcomes.

Cardiac troponin can be used as an independent early indicator of end-stage kidney disease, and death, new study suggests

The Pathologist’s Top 100 Power List celebrates the exceptional achievments of people in the field.